Jpmorgan Chase & CO Retractable Technologies Inc Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Retractable Technologies Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 31 shares of RVP stock, worth $23. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31
Previous 33
6.06%
Holding current value
$23
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RVP
# of Institutions
34Shares Held
4.79MCall Options Held
2.7KPut Options Held
100-
Wealthfront Advisers LLC2.53MShares$1.95 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA690KShares$530,9210.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny361KShares$278,1640.0% of portfolio
-
Black Rock Inc. New York, NY274KShares$210,9610.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX145KShares$111,5190.0% of portfolio
About RETRACTABLE TECHNOLOGIES INC
- Ticker RVP
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 32,937,200
- Market Cap $25.4M
- Description
- Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adap...